Business Description
Seres Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on developing oral treatments that work by restoring and strengthening the gut microbiome. Its pipeline includes therapies aimed at preventing serious infections in vulnerable patient populations, such as those receiving stem cell transplants or living with chronic liver disease. The company does this by targeting harmful bacteria in the gut and supporting the body's natural defenses. Founded in 2010, Seres has built its work around the idea that a healthier gut environment can lead to meaningfully better health outcomes.
